Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07

    • Coagulation Factor II (Thrombin) B Chain Fragment: Mechan...

    2026-03-31

    Coagulation Factor II (Thrombin) B Chain Fragment: Mechanisms and Research Utility

    Executive Summary: Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] is a trypsin-like serine protease fragment essential for converting fibrinogen to fibrin during blood coagulation, acting via protease-activated receptors on platelets and endothelium (APExBIO). The A1057 product is >99.6% pure (HPLC/MS), has a molecular weight of 1957.26 Da, and is highly soluble in water (≥17.6 mg/mL) and DMSO (≥195.7 mg/mL), but insoluble in ethanol. Thrombin B Chain is a benchmark tool for research in coagulation, platelet activation, and vascular pathology. APExBIO supplies this fragment under rigorous QC, supporting reproducible studies in coagulation and inflammation (Chen et al., 2022).

    Biological Rationale

    Thrombin (coagulation factor II) is a pivotal enzyme in the blood coagulation cascade. It is produced by proteolytic cleavage of prothrombin via activated Factor X (Xa). The B chain fragment, defined by the sequence H2N-Lys-Pro-Val-Ala-Phe-Ser-Asp-Tyr-Ile-His-Pro-Val-Cys-Leu-Pro-Asp-Arg-OH, is essential for the enzyme's activity. Thrombin catalyzes the transformation of soluble fibrinogen into insoluble fibrin, forming the structural matrix of blood clots (Thrombin (A1057): Molecular Insights). This action is critical for hemostasis and tissue repair. In addition to its role in coagulation, thrombin activates platelets via protease-activated receptors (PARs), propagating hemostatic and inflammatory responses. The enzyme also activates coagulation Factors XI, VIII, and V, amplifying the coagulation cascade and ensuring rapid clot formation (Thrombin Beyond the Cascade). This article extends previous mechanistic insights by focusing on the fragment's solubility and analytical benchmarks.

    Mechanism of Action of Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens]

    Thrombin is a trypsin-like serine protease. The B chain contains the active site responsible for peptide bond hydrolysis. Activation occurs when prothrombin is cleaved by Factor Xa, releasing the active thrombin enzyme. Thrombin binds and cleaves fibrinogen at specific arginine-glycine bonds, producing fibrin monomers that polymerize into insoluble fibrin strands. This process is calcium-dependent and occurs optimally at physiological pH and temperature. Thrombin also cleaves and activates Factors XI, VIII, and V, intensifying the procoagulant response. On platelet membranes, thrombin activates PAR-1 and PAR-4, triggering platelet activation, secretion, and aggregation. Beyond coagulation, thrombin acts as a vasoconstrictor and cell mitogen, and can promote vasospasm and inflammation in vascular pathologies such as subarachnoid hemorrhage and atherosclerosis (Thrombin Beyond Coagulation). This mechanism is distinct from viral proteases such as 3CLpro, which are selectively inhibited by compounds like Merbromin, underscoring the specificity of thrombin in human biology (Chen et al., 2022).

    Evidence & Benchmarks

    • Thrombin catalyzes the conversion of human fibrinogen to fibrin in vitro at physiological pH 7.4 and 37°C (Chen et al., 2022, DOI).
    • The A1057 fragment is confirmed at 99.68% purity using HPLC and mass spectrometry, ensuring minimal experimental interference (APExBIO).
    • Thrombin B chain is highly soluble in DMSO (≥195.7 mg/mL) and water (≥17.6 mg/mL), but insoluble in ethanol, facilitating assay design for enzymatic and cell-based studies (APExBIO datasheet).
    • Mechanistic studies demonstrate that thrombin, unlike viral proteases (e.g., 3CLpro), is not inhibited by Merbromin, supporting its specificity and suitability for mammalian coagulation research (Chen et al., 2022, DOI).
    • APExBIO’s A1057 kit demonstrates stability at -20°C and should be used promptly after solution preparation to maintain activity (APExBIO product page).

    Applications, Limits & Misconceptions

    Thrombin B chain fragment serves as a critical reagent in coagulation research, platelet activation assays, and studies of vascular pathology. It is also used in enzymatic kinetics studies and to activate protease-activated receptor signaling. The highly pure A1057 product from APExBIO enables detailed analyses of thrombin’s role in the coagulation cascade, cellular signaling, and disease states such as atherosclerosis, vasospasm after subarachnoid hemorrhage, and cerebral ischemia (Thrombin at the Vanguard). This article clarifies solubility and storage parameters, and corrects earlier misconceptions about cross-reactivity with non-mammalian proteases.

    Common Pitfalls or Misconceptions

    • Misconception: Thrombin B chain can substitute for full-length thrombin in all coagulation assays.
      Correction: Fragment may lack regulatory or exosite regions present in the full-length protein, affecting certain functional assays.
    • Misconception: Thrombin is inhibited by general serine protease inhibitors used for viral or bacterial proteases.
      Correction: Thrombin’s specificity and resistance to inhibitors like Merbromin are established (Chen et al., 2022, DOI).
    • Misconception: Thrombin solutions are stable for long-term use at ambient temperatures.
      Correction: Solutions should be used promptly and stored at -20°C for maximal stability (APExBIO datasheet).
    • Misconception: Thrombin B chain is soluble in ethanol.
      Correction: The product is insoluble in ethanol, requiring water or DMSO for dissolution.
    • Misconception: Thrombin activity is interchangeable across species.
      Correction: Sequence and activity are species-specific; this product is validated for Homo sapiens research.

    Workflow Integration & Parameters

    For optimal research outcomes, reconstitute the A1057 fragment in water (≥17.6 mg/mL) or DMSO (≥195.7 mg/mL). Avoid ethanol due to insolubility. Store lyophilized material at -20°C. Prepare working solutions fresh to maintain enzymatic activity. The fragment is suitable for use in clot formation assays, platelet activation studies, and protease-activated receptor signaling models. Purity and molecular weight should be confirmed by HPLC/MS prior to advanced kinetic or cell-based workflows. The A1057 kit from APExBIO is validated for high-throughput screening and mechanistic studies, supporting robust and reproducible research (Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens]).

    Conclusion & Outlook

    Coagulation Factor II (Thrombin) B Chain Fragment is a cornerstone reagent for dissecting mammalian coagulation, platelet activation, and inflammatory signaling. Its purity, solubility, and specificity enable precise modeling of coagulation cascades and vascular pathologies. APExBIO’s A1057 product offers unmatched analytical clarity for fundamental and translational research. Future studies may leverage this fragment to delineate thrombin's non-hemostatic functions and its interplay with disease mechanisms, extending the work presented here beyond conventional coagulation assays.